Evidence map›Paper›PMID 23710591›Full record

ArticleACS nano2013

Selecting improved peptidyl motifs for cytosolic delivery of disparate protein and nanoparticle materials.

Kelly Boeneman, James B Delehanty, Juan B Blanco-Canosa, Kimihiro Susumu, Michael H Stewart, Eunkeu Oh, Alan L Huston, Glyn Dawson, Sampat Ingale, Ryan Walters and 10 more

Abstract read
In one paragraph

Article in ACS nano, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 131 citations in OpenAlex.

  1. Pooled it
  2. Membrane-Targeted Quantum Dot-Based BACE1 Activity Sensors forACS applied materials & interfaces · 2024
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Implementing Multi-Enzyme Biocatalytic Systems Using Nanoparticle Scaffolds.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  8. Mitochondrial Targeting Probes, Drug Conjugates, and Gene Therapeutics.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 2 countries.

Kelly BoenemanCenter for Bio/Molecular Science and Engineering, Code 6900, US Naval Research Laboratory, Washington, DC 20375, United States.
James B Delehanty
Juan B Blanco-Canosa
Kimihiro Susumu
Michael H Stewart
Eunkeu Oh
Alan L Huston
Glyn Dawson
Sampat Ingale
Ryan Walters
Miriam Domowicz
Jeffrey R Deschamps
W Russ Algar
Stassi Dimaggio
Janet Manono
Christopher M Spillmann
Darren Thompson
Travis L Jennings
Philip E Dawson
Igor L Medintz
Scripps Research Institute · USSotera Defense Solutions (United States) · USXavier University of Louisiana · USGeorge Mason University · USInstitute for Research in Biomedicine · ES

Funding

XRAY CRYSTALLOGRAPHIC STRUCTURE ANALYSIS: PROTEIN SORTINGP41RR001081 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 1985 to 2011
$17.6M
Xavier's RCMI Cancer Research ProgramG12MD007595 · NIMHD · XAVIER UNIVERSITY OF LOUISIANA · PI D'AMOUR, GENE, WANG, GUANGDI · 2012 to 2018
$15.7M
THE MOLECULAR BASIS OF B-MANNOSIDOSISP01HD009402 · NICHD · UNIVERSITY OF CHICAGO · PI KRAIG, RICHARD P · 1985 to 2015
$13.0M
XAVIER'S RCMI CANCER RESEARCH PROGRAMG12RR026260 · NCRR · XAVIER UNIVERSITY OF LOUISIANA · PI WIESE, THOMAS E · 2009 to 2011
$7.0M
GLYCOSPHINGOLIPID METABOLISM AND MENTAL RETARDATIONR01NS036866 · NINDS · UNIVERSITY OF CHICAGO · PI DAWSON, GLYN · 1997 to 2015
$4.4M
NCRR NIH HHS 5G12RR026260-03NCRR NIH HHS G12 RR026260NCRR NIH HHS NIH P41 RR-01081NCRR NIH HHS P41 RR001081NICHD NIH HHS P01 HD009402NICHD NIH HHS USPHS HD09402NIMHD NIH HHS G12 MD007595NINDS NIH HHS R01 NS036866
6 · The paper itself

Abstract

Cell penetrating peptides facilitate efficient intracellular uptake of diverse materials ranging from small contrast agents to larger proteins and nanoparticles. However, a significant impediment remains in the subsequent compartmentalization/endosomal sequestration of most of these cargoes. Previous functional screening suggested that a modular peptide originally designed to deliver palmitoyl-protein thioesterase inhibitors to neurons could mediate endosomal escape in cultured cells. Here, we detail properties relevant to this peptide's ability to mediate cytosolic delivery of quantum dots (QDs) to a wide range of cell-types, brain tissue culture and a developing chick embryo in a remarkably nontoxic manner. The peptide further facilitated efficient endosomal escape of large proteins, dendrimers and other nanoparticle materials. We undertook an iterative structure-activity relationship analysis of the peptide by discretely modifying key components including length, charge, fatty acid content and their order using a comparative, semiquantitative assay. This approach allowed us to define the key motifs required for endosomal escape, to select more efficient escape sequences, along with unexpectedly identifying a sequence modified by one methylene group that specifically targeted QDs to cellular membranes. We interpret our results within a model of peptide function and highlight implications for in vivo labeling and nanoparticle-mediated drug delivery by using different peptides to co-deliver cargoes to cells and engage in multifunctional labeling.

Indexed as

Quantum DotsAmino Acid MotifsAmino Acid SequenceAnimalsCell LineCell-Penetrating PeptidesChick EmbryoCytosolDrug CarriersEndosomesHumansMaltose-Binding ProteinsMolecular Sequence DataCell-Penetrating PeptidesDrug CarriersMaltose-Binding Proteins

Identifiers

PMID23710591
PMCPMC3880025
OpenAlexW2055262131

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.